Demographic and Administrative Information Name (abbreviated): G.S.M. Gender: male Weight (kg): 90 Height (cm): 176 cm Admission Date: 23/9/2011 Marital Status: widower Case summary Past Medical
A.W.M., a 68 years old male is a known case of DM, HTN, A-fib, HF and IHD. He is
admitted to the hospital complaining of shortness of breath and severe abdominal
distension of one week duration and is diagnosed as a case of decompensated heart failure
with ascitis and digoxin toxicity. The patient underwent paracentesis on 25/9/2011.
On admission the patient suffered from decompensated HF, subset II, and acute kidney
Note: Upon the interview it appeared that A.W.M. took double the dose of digoxin and
carvedilol because of his vision problem. Life style: Diet: low salt diet Family History ETOH: none Caffeine: Occasional Physical Activity: Minimal Smoking: Non smoker
The patient suffers frommoderate visionimpairment. Chemistry and CBC Tests and Procedures Normal values Resp.Rate Random Blood glucose Fasting Blood glucose Digoxin Level Review of Systems Allergies -NKDA General – conscious, oriented, sleepy, fatigued, Physical exam: Eye-Ear-Throat: blurred vision Dermatology –mild bruises Respiratory: shortness of breath Gastroenterology: nausea, vomiting and diarrhea Neurology: dizziness
CV – freeAbd – Soft,non-distended; no massesor obvious tenderness,nausea, vomiting anddiarrhea. PTA Medication
Carvedilol 25 mg PO ½ x2 (since 3 months)
Digoxin 0.25 mg PO ½ x1 (since 3 months)
Amiodarone 200 mg PO 1x1 (since 2 weeks) Current Drug Therapy Indication Drug Name/Dose/Strength/Route Duration Start–Stop Prescribed Schedule (held on 25/9) (held on 23/9) (held on 23/9, restarted 25/9) Pharmacist care plan for current medications Treatment Related Issue Pharmacotherapy Recommendations (Pharmacological, Follow up and monitoring Problem or health care Questions: 1) What are the advantages and disadvantages of the new oral anticoagulant dabigatran in comparison to warfarin? 2) Is it rational to replace amiodarone with the less lipophilic drondarone in this patient? Justify your answer. 3) What are the advantages and disadvantages of the renin inhibitor Aliskiren in comparison to ACEIs and ARBs in the treatment of hypertension? Participant information 1. Full name (as in passport)______________________________ 2. Age _____ 3. Professional Degree ____________________________________ 4. Institution ___________________________________ 5. Country _________________________ 6. E-mail address _________________
Medical Exception / Precertification* Request Form For Prescription Medications Please complete form and fax to: 1-800-408-2386 or call 1-800-414-2386. Visit https://www.aetna.com/provweb/ to register to e-mail your requests for a faster response. Visit www.aetna.com/formulary to access the Pharmacy Coverage Policy Bulletins. Physician Signature ( REQUIRED ) Please circle
Electronic Communications Disclosure Note: This Electronic Communications Disclosure (“eCommunications Disclosure”) applies to communications that we are legally required to provide to you in writing and other communications that we provide to you in connection with any or all of your accounts, products and services. Please read this eCommunications Disclosure thoroughly – It cont
Demographic and Administrative Information
A.W.M., a 68 years old male is a known case of DM, HTN, A-fib, HF and IHD. He is
admitted to the hospital complaining of shortness of breath and severe abdominal
distension of one week duration and is diagnosed as a case of decompensated heart failure
with ascitis and digoxin toxicity. The patient underwent paracentesis on 25/9/2011.
Resp.Rate
CV – freeAbd – Soft,non-distended; no massesor obvious tenderness,nausea, vomiting anddiarrhea.
(held on 25/9)
Pharmacist care plan for current medications
Questions:
Participant information